These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 10715225)

  • 1. Effects of olestra and sorbitol consumption on objective measures of diarrhea: impact of stool viscosity on common gastrointestinal symptoms.
    McRorie J; Zorich N; Riccardi K; Bishop L; Filloon T; Wason S; Giannella R
    Regul Toxicol Pharmacol; 2000 Feb; 31(1):59-67. PubMed ID: 10715225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of wheat bran and Olestra on objective measures of stool and subjective reports of GI symptoms.
    McRorie J; Kesler J; Bishop L; Filloon T; Allgood G; Sutton M; Hunt T; Laurent A; Rudolph C
    Am J Gastroenterol; 2000 May; 95(5):1244-52. PubMed ID: 10811335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, placebo-controlled, consumer rechallenge test of Olean salted snacks.
    Zorich NL; Biedermann D; Riccardi KA; Bishop LJ; Filloon TG
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):200-9. PubMed ID: 9356283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review and analysis of the effects of olestra, a dietary fat substitute, on gastrointestinal function and symptoms.
    Freston JW; Ahnen DJ; Czinn SJ; Earnest DL; Farthing MJ; Gorbach SL; Hunt RH; Sandler RS; Schuster MM
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):210-8. PubMed ID: 9356284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal symptoms following consumption of olestra or regular triglyceride potato chips: a controlled comparison.
    Cheskin LJ; Miday R; Zorich N; Filloon T
    JAMA; 1998 Jan; 279(2):150-2. PubMed ID: 9440666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind, placebo-controlled, food allergy challenge to olestra snacks.
    Burks AW; Christie L; Althage KA; Kesler JM; Allgood GS
    Regul Toxicol Pharmacol; 2001 Oct; 34(2):178-81. PubMed ID: 11603960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dietary fibre and olestra on regional apparent viscosity and water content of digesta residue in porcine large intestine.
    McRorie J; Brown S; Cooper R; Givaruangsawat S; Scruggs D; Boring G
    Aliment Pharmacol Ther; 2000 Apr; 14(4):471-7. PubMed ID: 10759627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal symptoms in 3181 volunteers ingesting snack foods containing olestra or triglycerides. A 6-week randomized, placebo-controlled trial.
    Sandler RS; Zorich NL; Filloon TG; Wiseman HB; Lietz DJ; Brock MH; Royer MG; Miday RK
    Ann Intern Med; 1999 Feb; 130(4 Pt 1):253-61. PubMed ID: 10068382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal tolerance of erythritol and xylitol ingested in a liquid.
    Storey D; Lee A; Bornet F; Brouns F
    Eur J Clin Nutr; 2007 Mar; 61(3):349-54. PubMed ID: 16988647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of olestra on breath gas production and faecal microbial counts.
    Eastwood MA; Allgood GS
    Eur J Clin Nutr; 1995 Sep; 49(9):627-39. PubMed ID: 7498099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal responses following acute and medium term intake of retrograded resistant maltodextrins, classified as type 3 resistant starch.
    Storey D; Lee A; Bornet F; Brouns F
    Eur J Clin Nutr; 2007 Nov; 61(11):1262-70. PubMed ID: 17299489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olestra at the movies.
    Harv Heart Lett; 1998 May; 8(9):7-8. PubMed ID: 9579116
    [No Abstract]   [Full Text] [Related]  

  • 13. Dose-related gastrointestinal response to the ingestion of either isomalt, lactitol or maltitol in milk chocolate.
    Koutsou GA; Storey DM; Lee A; Zumbe A; Flourie B; leBot Y; Olivier Ph
    Eur J Clin Nutr; 1996 Jan; 50(1):17-21. PubMed ID: 8617186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: olestra and its gastrointestinal safety.
    Thomson AB; Hunt RH; Zorich NL
    Aliment Pharmacol Ther; 1998 Dec; 12(12):1185-200. PubMed ID: 9882026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olestra dose response on fat-soluble and water-soluble nutrients in humans.
    Schlagheck TG; Riccardi KA; Zorich NL; Torri SA; Dugan LD; Peters JC
    J Nutr; 1997 Aug; 127(8 Suppl):1646S-1665S. PubMed ID: 9237961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mysterious case of loose stools and GI cramps.
    Porterfield LM
    RN; 1997 Jan; 60(1):67. PubMed ID: 9016170
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of the moderate consumption of olestra in patients receiving long-term warfarin therapy.
    Beckey NP; Korman LB; Parra D
    Pharmacotherapy; 1999 Sep; 19(9):1075-9. PubMed ID: 10610014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative gastrointestinal responses of children and adults following consumption of sweets formulated with sucrose, isomalt and lycasin HBC.
    Lee A; Wils D; Zumbé A; Storey DM
    Eur J Clin Nutr; 2002 Aug; 56(8):755-64. PubMed ID: 12122552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal symptoms following olestra consumption.
    Jacobson MF; Brown MA; Whorton EB
    JAMA; 1998 Jul 22-29; 280(4):325-7. PubMed ID: 9686546
    [No Abstract]   [Full Text] [Related]  

  • 20. The comparative gastrointestinal response of young children to the ingestion of 25 g sweets containing sucrose or isomalt.
    Storey DM; Lee A; Zumbé A
    Br J Nutr; 2002 Apr; 87(4):291-7. PubMed ID: 12064338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.